Guardant Health, Inc. (GH): Price and Financial Metrics
GH Price/Volume Stats
| Current price | $61.28 | 52-week high | $62.08 |
| Prev. close | $58.50 | 52-week low | $20.14 |
| Day low | $57.94 | Volume | 2,637,000 |
| Day high | $62.08 | Avg. volume | 2,399,109 |
| 50-day MA | $49.97 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 7.64B |
GH Stock Price Chart Interactive Chart >
Guardant Health, Inc. (GH) Company Bio
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.
GH Price Returns
| 1-mo | 34.83% |
| 3-mo | 61.26% |
| 6-mo | 42.94% |
| 1-year | 119.88% |
| 3-year | 27.75% |
| 5-year | -34.45% |
| YTD | 100.59% |
| 2024 | 12.94% |
| 2023 | -0.55% |
| 2022 | -72.81% |
| 2021 | -22.39% |
| 2020 | 64.93% |
Continue Researching GH
Want to do more research on Guardant Health Inc's stock and its price? Try the links below:Guardant Health Inc (GH) Stock Price | Nasdaq
Guardant Health Inc (GH) Stock Quote, History and News - Yahoo Finance
Guardant Health Inc (GH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...